Literature DB >> 22014570

FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis.

Nu Zhang1, Ping Wei, Aihua Gong, Wen-Tai Chiu, Hsueh-Te Lee, Howard Colman, He Huang, Jianfei Xue, Mingguang Liu, Yong Wang, Raymond Sawaya, Keping Xie, W K Alfred Yung, René H Medema, Xi He, Suyun Huang.   

Abstract

Wnt/β-catenin signaling is essential for stem cell regulation and tumorigenesis, but its molecular mechanisms are not fully understood. Here, we report that FoxM1 is a downstream component of Wnt signaling and is critical for β-catenin transcriptional function in tumor cells. Wnt3a increases the level and nuclear translocation of FoxM1, which binds directly to β-catenin and enhances β-catenin nuclear localization and transcriptional activity. Genetic deletion of FoxM1 in immortalized neural stem cells abolishes β-catenin nuclear localization. FoxM1 mutations that disrupt the FoxM1-β-catenin interaction or FoxM1 nuclear import prevent β-catenin nuclear accumulation in tumor cells. FoxM1-β-catenin interaction controls Wnt target gene expression, is required for glioma formation, and represents a mechanism for canonical Wnt signaling during tumorigenesis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014570      PMCID: PMC3199318          DOI: 10.1016/j.ccr.2011.08.016

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  27 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

Review 2.  The ins and outs of APC and beta-catenin nuclear transport.

Authors:  Beric R Henderson; Francois Fagotto
Journal:  EMBO Rep       Date:  2002-09       Impact factor: 8.807

3.  Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues.

Authors:  H Ye; T F Kelly; U Samadani; L Lim; S Rubio; D G Overdier; K A Roebuck; R H Costa
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 4.  Brain tumor-polyposis syndrome: two genetic diseases?

Authors:  F Paraf; S Jothy; E G Van Meir
Journal:  J Clin Oncol       Date:  1997-07       Impact factor: 44.544

5.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.

Authors:  Vladimir V Kalinichenko; Michael L Major; Xinhe Wang; Vladimir Petrovic; Joseph Kuechle; Helena M Yoder; Margaret B Dennewitz; Brian Shin; Abhishek Datta; Pradip Raychaudhuri; Robert H Costa
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

6.  Regulation of cerebral cortical size by control of cell cycle exit in neural precursors.

Authors:  Anjen Chenn; Christopher A Walsh
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

7.  Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function.

Authors:  Fiona M Townsley; Adam Cliffe; Mariann Bienz
Journal:  Nat Cell Biol       Date:  2004-06-20       Impact factor: 28.824

Review 8.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

9.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

10.  FoxM1 regulates re-annealing of endothelial adherens junctions through transcriptional control of beta-catenin expression.

Authors:  Muhammad K Mirza; Ying Sun; Yidan D Zhao; Hari-Hara S K Potula; Randall S Frey; Steven M Vogel; Asrar B Malik; You-Yang Zhao
Journal:  J Exp Med       Date:  2010-07-26       Impact factor: 14.307

View more
  267 in total

1.  FoxM1: a potential drug target for glioma.

Authors:  Yu Li; Sicong Zhang; Suyun Huang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

Review 2.  Oxygen levels and the regulation of cell adhesion in the nervous system: a control point for morphogenesis in development, disease and evolution?

Authors:  Kathryn L Crossin
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

3.  Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.

Authors:  Ming Quan; Jiujie Cui; Tian Xia; Zhiliang Jia; Dacheng Xie; Daoyan Wei; Suyun Huang; Qian Huang; Shaojiang Zheng; Keping Xie
Journal:  Cancer Res       Date:  2015-10-19       Impact factor: 12.701

4.  Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway.

Authors:  Boyan Huang; Peiqiang Mu; Yan Yu; Wenya Zhu; Tianqing Jiang; Rong Deng; Gongkan Feng; Jikai Wen; Xiaofeng Zhu; Yiqun Deng
Journal:  Gastric Cancer       Date:  2020-06-11       Impact factor: 7.370

5.  Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.

Authors:  De-Chen Lin; Liang Xu; Ye Chen; Haiyan Yan; Masaharu Hazawa; Ngan Doan; Jonathan W Said; Ling-Wen Ding; Li-Zhen Liu; Henry Yang; Shizhu Yu; Michael Kahn; Dong Yin; H Phillip Koeffler
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

6.  CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.

Authors:  Kazuya Fukasawa; Takuya Kadota; Tetsuhiro Horie; Kazuya Tokumura; Ryuichi Terada; Yuka Kitaguchi; Gyujin Park; Shinsuke Ochiai; Sayuki Iwahashi; Yasuka Okayama; Manami Hiraiwa; Takanori Yamada; Takashi Iezaki; Katsuyuki Kaneda; Megumi Yamamoto; Tatsuya Kitao; Hiroaki Shirahase; Masaharu Hazawa; Richard W Wong; Tomoki Todo; Atsushi Hirao; Eiichi Hinoi
Journal:  Oncogene       Date:  2021-03-16       Impact factor: 9.867

7.  Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers.

Authors:  Mireia Nàger; Marta C Sallán; Anna Visa; Charumathi Pushparaj; Maria Santacana; Anna Macià; Andrée Yeramian; Carles Cantí; Judit Herreros
Journal:  Autophagy       Date:  2018-02-21       Impact factor: 16.016

8.  FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.

Authors:  Ai-Hua Gong; Ping Wei; Sicong Zhang; Jun Yao; Ying Yuan; Ai-Dong Zhou; Frederick F Lang; Amy B Heimberger; Ganesh Rao; Suyun Huang
Journal:  Cancer Res       Date:  2015-04-01       Impact factor: 12.701

Review 9.  Glioblastoma stem cells: Molecular characteristics and therapeutic implications.

Authors:  Nermin Sumru Bayin; Aram Sandaldjian Modrek; Dimitris George Placantonakis
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

10.  Association of FOXM1 expression with tumor histology and prognosis in Wilms tumor: Potential for a new prognostic marker.

Authors:  Nadja Apelt; Jochen Hubertus; Doris Mayr; Norbert Graf; Rhoikos Furtwängler; Dietrich Von Schweinitz; Roland Kappler
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.